Ågren, U. M., M. Tammi, M. Ryynänen, and R. Tammi. Developmentally programmed expression of hyaluronan in human skin and its appendages. J. Invest. Dermatol. 109:219–224, 1997.
Amagai, M., P. J. Koch, T. Nishikawa, and J. R. Stanley. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J. Invest. Dermatol. 106:351–353, 1996.
Balaz, E. A., and T. C. Laurent. New applications for hyaluronan. In: The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives, edited by T. C. Laurent. Wenner-Gren Symposium, 1998, (72), p. S.325.
Bedoni, M., C. Sforza, C. Dolci, and E. Donetti. Proliferation and differentiation biomarkers in normal human breast skin organotypic cultures. J. Dermatol. Sci. 46:139–142, 2007.
Blanton, R. A., M. D. Coltrera, A. M. Gown, C. L. Halbert, and J. K. McDougall. Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth Diff. 3:791–802, 1992.
Breitkreutz, D., H. J. Stark, N. Mirancea, P. Tomakidi, H. Steinbauer, and N. E. Fusenig. Integrin and basement membrane normalization in mouse grafts of human keratinocytes—implications for epidermal homeostasis. Differentiation 61:195–209, 1997.
Buntrock, P., K. D. Jentzsch, and G. Heder. Stimulation of wound healing, using brain extract with fibroblast growth factor (FGF) activity. I. Quantitative and biochemical studies into formation of granulation tissue. Exp. Pathol. 21:46–53, 1982.
Campbell, A. A., L. Song, X. S. Li, B. J. Nelson, C. Bottoni, D. E. Brooks, and E. S. DeJong. Development, characterization, and anti-microbial efficacy of hydroxyapatite-chlorhexidine coatings produced by surface-induced mineralization. J. Biomed. Mater. Res. 53:400–407, 2000.
Campo, G. M., A. Avenoso, S. Campo, A. D’Ascola, P. Traina, D. Samà, and A. Calatroni. NF-kB and caspases are involved in the hyaluronan and chondroitin-4-sulphate-exerted antioxidant effect in fibroblast cultures exposed to oxidative stress. J. Appl. Toxicol. 28:509–517, 2008.
Carruthers, J., and A. Carruthers. Hyaluronic acid gel in skin rejuvenation. J. Drugs Dermatol. 5:959–964, 2006.
Dechert, T. A., A. E. Ducale, S. I. Ward, and D. R. Yager. Hyaluronan in human acute and chronic dermal wounds. Wound Repair Regen. 14:252–258, 2006.
Dunphy, J. E., and K. N. Udupa. Chemical and histochemical sequences in the normal healing of wounds. N. Engl. J. Med. 253:847–851, 1955.
El Ghalbzouri, A., M. F. Jonkman, R. Dijkman, and M. Ponec. Basement membrane reconstruction in human skin equivalents is regulated by fibroblasts and/or exogenously activated keratinocytes. J. Invest. Dermatol. 124:79–86, 2005.
Elkayam, O., I. Yaron, I. Shirazi, M. Yaron, and D. Caspi. Serum levels of hyaluronic acid in patients with psoriatic arthritis. Clin. Rheumatol. 19:455–457, 2000.
Engstrom-Laurent, A., N. Feltelius, R. Hallgren, and A. Wasteson. Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells? Ann. Rheum. Dis. 44:614–620, 1985.
Freitas, J. P., P. Filipe, I. Emerit, P. Meunier, C. F. Manso, and F. Guerra Rodrigo. Hyaluronic acid in progressive systemic sclerosis. Dermatology 192:46–49, 1996.
Gallo, R. L., and M. Bernfield. Proteoglycans and their role in wound repair. In: The Molecular and Cellular Biology of Wound Repair, 2nd edn., Chap. 15, edited by R. F. Clark. New York: Plenum Press, 1996.
Gawronska-Kozak, B., M. Bogacki, J. S. Rim, W. T. Monroe, and J. A. Manuel. Scarless skin repair in immunodeficient mice. Wound Repair Regen. 14:265–276, 2006.
Gupta, D., C. H. Tator, and M. S. Shoichet. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 27:2370–2379, 2006.
Hebda, P. A., C. K. Klingbeil, J. A. Abraham, and J. C. Fiddes. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J. Invest. Dermatol. 95:626–631, 1990.
Jia, C., C. He, G. W. Cherry, B. Carbow, W. Meyer-Ingold, D. Bader, and D. C. West. Hyaluronan, heterogeneity, and healing: the effects of ultrapure hyaluronan of defined molecular size on the repair of full-thickness pig skin wounds. Wound Repair Regen. 3:299–310, 1995.
Kawashima, H., K. Atarashi, M. Hirose, J. Hirose, S. Yamada, K. Sugahara, and M. Miyasaka. Oversulfated chondroitin/dermatan sulfates containing GlcAβ1/IdoAα1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 277:12921–12930, 2002.
Knowles, N. G., Y. Miyashita, M. L. Usui, A. J. Marshall, A. Pirrone, K. D. Hauch, B. D. Ratner, R. A. Underwood, P. Fleckman, and J. E. Olerud. A model for studying epithelial attachment and morphology at the interface between skin and percutaneous devices. J. Biomed. Mater. Res. A 74:482–488, 2005.
Koshiishi, I., E. Horikoshi, and T. Imanari. Quantification of hyaluronan and chondroitin/dermatan sulfates in the tissue sections on glass slides. Anal. Biochem. 267:222–226, 1999.
Kubo, M., H. Ihn, A. Matsukawa, K. Kikuchi, and K. Tamaki. Dermatomyositis with elevated serum hyaluronate. Clin. Exp. Dermatol. 24:275–278, 1999.
Longaker, M. T., E. S. Chiu, N. S. Adzick, M. Stern, M. R. Harrison, and R. Stern. Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann. Surg. 213:292–296, 1991.
Lundgren, D., and R. Axelsson. Soft-tissue-anchored percutaneous device for long-term intracorporeal access. J. Invest. Surg. 2:17–27, 1989.
Lundin, A., A. Engstrom-Laurent, R. Hallgren, and G. Michaelsson. Circulating hyaluronate in psoriasis. Br. J. Dermatol. 112:663–671, 1985.
Lundin, A., A. Engstrom-Laurent, G. Michaelsson, and A. Tengblad. High levels of hyaluronate in suction blister fluid from active psoriatic lesions. Br. J. Dermatol. 116:335–340, 1987.
Maas-Szabowski, N., H. J. Stark, and N. E. Fusenig. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J. Invest. Dermatol. 114:1075–1084, 2000.
Mahan, J., D. Seligson, S. L. Henry, P. Hynes, and J. Dobbins. Factors in pin tract infections. Orthopedics 14:305–308, 1991.
Martikainen, A. L., M. Tammi, and R. Tammi. Proteoglycans synthesized by adult human epidermis in whole skin organ culture. J. Invest. Dermatol. 99:623–628, 1992.
McGee, G. S., J. M. Davidson, A. Buckley, A. Sommer, S. C. Woodward, A. M. Aquino, R. Barbour, and A. A. Demetriou. Recombinant basic fibroblast growth factor accelerates wound healing. J. Surg. Res. 45:145–153, 1988.
McKee, C. M., M. B. Penno, M. Cowman, M. D. Burdick, R. M. Strieter, C. Bao, and P. W. Noble. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 98:2403–2413, 1996.
Pasonen-Seppanen, S., S. Karvinen, K. Torronen, J. M. Hyttinen, T. Jokela, M. J. Lammi, M. I. Tammi, and R. Tammi. EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. J. Invest. Dermatol. 120:1038–1044, 2003.
Passi, A., P. Sadeghi, H. Kawamura, S. Anand, N. Sato, L. E. White, V. C. Hascall, and E. V. Maytin. Hyaluronan suppresses epidermal differentiation in organotypic cultures of rat keratinocytes. Exp. Cell Res. 296:123–134, 2004.
Passos, C. O., C. C. Werneck, G. R. Onofre, E. A. Pagani, A. L. Filgueira, and L. C. Silva. Comparative biochemistry of human skin: glycosaminoglycans from different body sites in normal subjects and in patients with localized scleroderma. J. Eur. Acad. Dermatol. Venereol. 17:14–19, 2003.
Penc, S. F., B. Pomahac, T. Winkler, R. A. Dorschner, E. Eriksson, M. Herndon, and R. L. Gallo. Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J. Biol. Chem. 273:28116–28121, 1998.
Pendergrass, C. J., A. E. Goodship, and G. W. Blunn. Development of a soft tissue seal around bone-anchored transcutaneous amputation prostheses. Biomaterials 27:4183–4191, 2006.
Penneys, N. S., J. E. Fulton, Jr., G. D. Weinstein, and P. Frost. Location of proliferating cells in human epidermis. Arch. Dermatol. 101:323–327, 1970.
Peramo, A., C. L. Marcelo, S. A. Goldstein, and D. C. Martin. Novel organotypic cultures of human skin explants with an implant-tissue biomaterial interface. Ann. Biomed. Eng. 37:401–409, 2009.
Pickup, J. C., F. Hussain, N. D. Evans, and N. Sachedina. In vivo glucose monitoring: the clinical reality and the promise. Biosens. Bioelectron. 20:1897–1902, 2005 (Review).
Resau, J. H., K. Sakamoto, J. R. Cottrell, E. A. Hudson, and S. J. Meltzer. Explant organ culture: a review. Cytotechnology 7:137–149, 1991.
Savage, Jr., C. R., and S. Cohen. Proliferation of corneal epithelium induced by epidermal growth factor. Exp. Eye Res. 15:361–366, 1973.
Shafritz, T. A., L. C. Rosenberg, and I. V. Yannas. Specific effects of glycosaminoglycans in an analog of extracellular matrix that delays wound contraction and induces regeneration. Wound Repair Regen. 2:270–276, 1994.
Sivan, V., M. C. Vozenin-Brotons, Y. Tricaud, J. L. Lefaix, J. M. Cosset, B. Dubray, and M. T. Martin. Altered proliferation and differentiation of human epidermis in cases of skin fibrosis after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 53:385–393, 2002.
Sondergaard, K., L. Heickendorff, L. Risteli, J. Risteli, H. Zachariae, K. Stengaard-Pedersen, and B. Deleuran. Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Br. J. Dermatol. 136:47–53, 1997.
Stern, R. Devising a pathway for hyaluronan catabolism: Are we there yet? Glycobiology 13:105R–115R, 2003.
Stoscheck, C. M., L. B. Nanney, and L. E. King, Jr. Quantitative determination of EGF-R during epidermal wound healing. J. Invest. Dermatol. 99:645–649, 1992.
Svensjo, T., B. Pomahac, F. Yao, J. Slama, and E. Eriksson. Accelerated healing of full-thickness skin wounds in a wet environment. Plast. Reconstr. Surg. 106:602–612, 2000.
Tammi, M. I., A. J. Day, and E. A. Turley. Hyaluronan and homeostasis: a balancing act. J. Biol. Chem. 277:4581–4584, 2002.
Trautmann, A., F. Altznauer, M. Akdis, H. U. Simon, R. Disch, E. B. Brocker, K. Blaser, and C. A. Akdis. The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J. Invest. Dermatol. 117:927–934, 2001.
Tsuboi, R., and D. B. Rifkin. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J. Exp. Med. 172:245–251, 1990.
Varani, J., S. E. G. Fligiel, L. Schuger, P. Perone, D. R. Inman, C. E. M. Griffiths, and J. J. Voorhees. Effects of all-trans retinoic acid and Ca2+ on human skin in organ culture. Am. J. Pathol. 142:189–198, 1993.
Voinchet, V., P. Vasseur, and J. Kern. Efficacy and safety of hyaluronic acid in the management of acute wounds. Am. J. Clin. Dermatol. 7:353–357, 2006.
Von Recum, A. F. Applications and failure modes of percutaneous devices: a review. J. Biomed. Mater. Res. 18:323–336, 1984.
Wang, C., M. Tammi, and R. Tammi. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 98:105–112, 1992.
Wang, T. W., H. C. Wu, Y. C. Huang, J. S. Sun, and F. H. Lin. Biomimetic bilayered gelatin-chondroitin 6 sulfate-hyaluronic acid biopolymer as the scaffold for skin equivalent tissue engineering. Artif. Organs 30:141–149, 2006.
Welss, T., D. A. Basketter, and K. R. Schröder. In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol. In Vitro 8:231–243, 2004.
Winter, G. D. Transcutaneous implants: reactions of the skin-implant interface. J. Biomed. Mater. Res. 8:99–113, 1974.
Xu, W., D. H. Xu, and A. D. Crocombe. Three-dimensional finite element stress and strain analysis of a transfemoral osseointegration implant. Proc. Inst. Mech. Eng. [H]: J. Eng. Med. 220:661–670, 2006.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4